4.7 Review

Endoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells

Journal

MOLECULAR METABOLISM
Volume 6, Issue 9, Pages 1024-1039

Publisher

ELSEVIER
DOI: 10.1016/j.molmet.2017.06.001

Keywords

Diabetes; Endoplasmic reticulum stress; eIF2 alpha; Pancreatic beta cell; Insulin; Islet

Funding

  1. European Union [667191]
  2. Fonds National de la Recherche Scientifique (FNRS)
  3. Actions de Recherche Concertees de la Communaute Francaise (ARC)
  4. Eye Hope Fund
  5. Innovative Medicines Initiative 2 Joint Undertaking Rhapsody - European Union [115881]
  6. EFPIA
  7. Swiss State Secretariat for Education' Research and Innovation (SERI) [16.0097]

Ask authors/readers for more resources

Background: Pancreatic beta cell dysfunction and death are central in the pathogenesis of most if not all forms of diabetes. Understanding the molecular mechanisms underlying beta cell failure is important to develop beta cell protective approaches. Scope of review: Here we review the role of endoplasmic reticulum stress and dysregulated endoplasmic reticulum stress signaling in beta cell,failure in monogenic and polygenic forms of diabetes. There is substantial evidence for the presence of endoplasmic reticulum stress in beta cells in type 1 and type 2 diabetes. Direct evidence for the importance of this stress response is provided by an increasing number of monogenic forms of diabetes. In particular, mutations in the PERK branch of the unfolded protein response provide insight into its importance for human beta cell function and survival. The knowledge gained from different rodent models is reviewed. More disease- and patient-relevant models, using human induced pluripotent stem cells differentiated into beta cells, will further advance our understanding of pathogenic mechanisms. Finally, we review the therapeutic modulation of endoplasmic reticulum stress and signaling in beta cells. Major conclusions: Pancreatic beta cells are sensitive to excessive endoplasmic reticulum stress and dysregulated eIF2 alpha phosphorylation, as indicated by transcriptome data, monogenic forms of diabetes and pharmacological studies. This should be taken into consideration when devising new therapeutic approaches for diabetes. (C) 2017 The Authors, Published by Elsevier GmbH.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available